Skip to NavigationSkip to content

Mission Therapeutics appoints Dr Colin Goddard to its board of directors

Published on: 02/07/15

MISSION Therapeutics, a drug discovery and development company today has appointed Dr Colin Goddard, former chief executive of OSI Pharmaceuticals, to the company’s board of directors.

“We are privileged to have Dr Goddard join our board at this exciting phase of Mission growth and development”, comments Michael Moore, chairman of MISSION Therapeutics.

Dr Goddard joined OSI as a research scientist in 1989 and led the transformation of the technology platform services company into a profitable, fully integrated biopharma firm, becoming chief executive in 1998.

Goddard was pivotal in the registration and launch of OSI’s targeted therapeutic product, Tarceva (erlotinib) and also directed the company’s financing, corporate development and acquisition strategies, completing several major acquisitions and divestitures and raising over $1.5bn in capital. 

Dr Goddard obtained his PhD in cancer pharmacology from the University of Aston in Birmingham, and worked at the US National Cancer Institute in Bethesda, Maryland, before joining OSI. 

He currently serves as executive chairman of US based biotech companies Coferon and Merganser Biotech and as a director on the boards of Endocyte and PanOptica, he was formerly a director at Human Genome Sciences.

"Dr Goddard has more than 25 years of outstanding leadership experience in the US biopharmaceutical industry and will add a complementary strategic dimension to our board.  We look forward to benefiting from his corporate vision, as we continue to transition our business into a clinical stage organisation.”

Dr Anker Lundemose, chief executive of MISSION Therapeutics added: “We are pleased to welcome Dr Goddard to MISSION Therapeutics.  His experience and track record in clinical development will be invaluable as we look to develop new drugs that will significantly improve the management of cancer.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches